The DOI matches its Crossref record; 81 of the 83 references it cites were found in a registry or an index.
Interferon Consensus sequence-Binding Protein, a Member of the Interferon Regulatory Factor Family, Suppresses Interferon-Induced Gene Transcription
Open accessAbstract
We previously isolated a cDNA clone encoding interferon consensus sequence-binding protein (ICSBP), a member of the interferon regulatory factor (IRF) family, that binds to the interferon (IFN)-stimulated response element (ISRE) of many IFN-regulated genes. In this investigation, we studied the functional role of ICSBP by transient cotransfection of ICSBP cDNA with IFN-responsive reporter genes into the human embryonal carcinoma cell line N-Tera2. These cells were shown not to express ICSBP or IRF-2, thus allowing functional analysis of transfected cDNAs. Cotransfection of ICSBP into cells treated with retinoic acid or any of the IFNs (alpha, beta, or gamma) repressed expression of a chloramphenicol acetyltransferase reporter driven by the major histocompatibility complex class I gene promoter. Similarly, ICSBP repressed expression of chloramphenicol acetyltransferase reporters driven by the ISREs of the 2'-5' oligoadenylate synthetase, guanylate-binding protein, and ISG-15 genes in IFN-treated cells. The repression was dependent on the presence of the ISRE in the reporter. Deletion analysis showed that the putative N-terminal DNA binding domain of ICSBP by itself is capable of mediating the repression. Using the same cotransfection conditions as for ICSBP, a similar repression of these reporters was observed with IRF-2. Finally, ICSBP repressed the IRF-1-mediated induction of major histocompatibility complex class I and IFN-beta reporters in the absence of IFN or retinoic acid. Taken together, these results suggest that ICSBP is a negative regulatory factor capable of repressing transcription of target genes induced by IFN, retinoic acid, or IRF-1.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ICSBP/IRF8 is expressed exclusively in myeloid and B-cells (10)”
In the citing paper
“Likewise, previous reporter analysis indicated that ICSBP is a repressor of ISRE-dependent transcription (36, 57).”
From Gamma Interferon Triggers Interaction between ICSBP (IRF-8) and TEL, Recruiting the Histone Deacetylase HDAC3 to the Interferon-Responsive Element (2002) · cites this paper as [36]
In the citing paper
“transfection of ICSBP alone reduced ISRE reporter activity by ∼ 40% irrespective of IFN𝛄 treatment, consistent with the previous finding that ICSBP represses ISRE-dependent transcription (36, 57).”
From Gamma Interferon Triggers Interaction between ICSBP (IRF-8) and TEL, Recruiting the Histone Deacetylase HDAC3 to the Interferon-Responsive Element (2002) · cites this paper as [36]
In the citing paper
“Subsequent studies have shown that ICSBP is a transcriptional repressor acting through the IFN-stimulated response element (ISRE). (6,20,21)”
From Review: ICSBP/IRF-8: Its Regulatory Roles in the Development of Myeloid Cells (2002) · cites this paper as [20]
Citations
Cites
Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1006/abio.1987.9999 · Cited by 65,515
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,512
Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase
Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., & Erlich, H. A. (1988) · Science · doi:10.1126/science.2448875 · Cited by 17,719
Nathan, C. F., Murray, H. W., Wiebe, M. E., & Rubin, B. Y. (1983) · The Journal of experimental medicine · doi:10.1084/jem.158.3.670 · Cited by 1,962
Pestka, S., Langer, J. A., Zoon, K. C., & Samuel, C. E. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.003455 · Cited by 1,826
Lymphokine Control of In Vivo Immunoglobulin Isotype Selection
Finkelman, F. D., Holmes, J. M., Katona, I. M., Urban, J. F., Beckmann, M. P., Park, L. S., Schooley, K., Coffman, R. L., Mosmann, T. R., & Paul, W. E. (1990) · Annual Review of Immunology · doi:10.1146/annurev.iy.08.040190.001511 · Cited by 1,301
Gorman, C. M., Merlino, G. T., Willingham, M. C., Pastan, I. H., & Howard, B. H. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.22.6777 · Cited by 1,257
Stewart, W. E. (1979) · Springer eBooks · doi:10.1007/978-3-7091-3432-0 · Cited by 1,165
Miyamoto, M., Fujita, T., Kimura, Y., Maruyama, M., Harada, H., Sudo, Y., Miyata, T., & Taniguchi, T. (1988) · Cell · doi:10.1016/s0092-8674(88)91307-4 · Cited by 971
Harada, H., Fujita, T., Miyamoto, M., Kimura, Y., Maruyama, M., Furia, A., Miyata, T., & Taniguchi, T. (1989) · Cell · doi:10.1016/0092-8674(89)90107-4 · Cited by 957
Flagged first, then by citations
2 of the 83 references couldn’t be matched to a known paper.
Research works printed but not linked: 12
- 10.1128/mcb.10.10.5055-5063.1990 · DOI
- 10.1128/mcb.7.12.4498-4504.1987 · DOI
- 10.1016/0003-2697(87)90021-2 · DOI
- 10.1128/mcb.11.10.5147-5153.1991 · DOI
- 10.1128/mcb.12.8.3590-3599.1992 · DOI
- 10.1128/mcb.11.1.182-191.1991 · DOI
- 10.1128/mcb.12.1.1-9.1992 · DOI
- 10.1128/mcb.9.11.4605-4612.1989 · DOI
- 10.1128/mcb.10.6.2448-2457.1990 · DOI
- 10.1128/mcb.7.7.2625-2630.1987 · DOI
- 10.1128/mcb.12.8.3315-3324.1992 · DOI
- Weisz A. P. Marx R. Sharf E. Appella P. H. Driggers K. Ozato and B. Levi. The cloning and characterization of the human homologue of ICSBP that binds enhancer element common to interferon inducible genes. J. Biol. Chem. in press.
Cited by
Sorted by citations
Items 101–192 of 192
Sato, T., Selleri, C., Young, N. S., & Maciejewski, J. P. (1995) · Blood · doi:10.1182/blood.v86.9.3373.bloodjournal8693373 · Cited by 47
Georgel, P., Kappler, C., Langley, E., Groß, I., Nicolas, E., Reichhart, J., & Hoffmann, J. A. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.7.1140 · Cited by 47
Type I interferons and autoimmunity: lessons from the clinic and from IRF-2-deficient mice
Taki, S. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(02)00023-0 · Cited by 48
“As we and others have shown [89,102,103], IRF-2 also represses the IRF-9-dependent gene expression (see later).”
BackgroundHuang, W., Zhou, W. J., Saberwal, G. S., Konieczna, I., Horvath, E., Katsoulidis, E., Platanias, L. C., & Eklund, E. A. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01595-09 · Cited by 45
Xiong, H., Li, H., Kong, H. J., Chen, Y., Zhao, J., Xiong, S., Huang, B., Gu, H., Mayer, L., Ozato, K., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414296200 · Cited by 44
Self-citationFagerlie, S. R., Diaz, J., Christianson, T. A., McCartan, K., Keeble, W. W., Faulkner, G. R., & Bagby, G. C. (2001) · Blood · doi:10.1182/blood.v97.10.3017 · Cited by 43
Jayakumar, A., Donovan, M. J., Tripathi, V., Ramalho-Ortigão, M., & McDowell, M. A. (2008) · Infection and Immunity · doi:10.1128/iai.01252-07 · Cited by 42
“sor (34, 53, 54), it assumes the role of an activator with regard”
BackgroundPiskurich, J. F., Gilbert, C. A., Ashley, B. D., Zhao, M., Chen, H., Wu, J., Bolick, S. C. E., & Wright, K. L. (2005) · Molecular Immunology · doi:10.1016/j.molimm.2005.05.005 · Cited by 41
“Some members of the IRF family, including IRF-4 and IRF-8/ICSBP, are expressed in uninduced B lymphocytes and recent studies show that IRF-4 activates CIITA pIII (Nelson et al., 1993;Eisenbeis et al., 1995;van der Stoep et al., 2004).”
BackgroundHuang, W., Saberwal, G., Horvath, E., Zhu, C., Lindsey, S., & Eklund, E. A. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00036-06 · Cited by 41
Interferon Consensus Sequence Binding Protein Confers Resistance against Yersinia enterocolitica
Hein, J., Kempf, V. A. J., Diebold, J., Bücheler, N., Preger, S., Horak, I., Sing, A., Kramer, U., & Autenrieth, I. B. (2000) · Infection and Immunity · doi:10.1128/iai.68.3.1408-1417.2000 · Cited by 39
Bluyssen, H. A., Vlietstra, R., van der Made, A. V. D., & Trapman, J. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb18636.x · Cited by 42
The interferon-inducible murine p48 (ISGF3γ) gene is regulated by protooncogene c- myc
Weihua, X., Lindner, D. J., & Kalvakolanu, D. V. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7227 · Cited by 39
Cha, Y., & Deisseroth, A. B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37685-8 · Cited by 39
Petricoin, E. F., David, M., Fang, H., Grimley, P. M., Larner, A. C., & Pol, S. V. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.2.1477 · Cited by 39
Mechanisms of Interferon Action
Leaman, D. W. (1998) · Progress in molecular and subcellular biology · doi:10.1007/978-3-642-72149-6_6 · Cited by 39
Drew, P. D., Franzoso, G., Carlson, L. M., Biddison, W. E., Siebenlist, U. K., & Ozato, K. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00140-9 · Cited by 38
Self-citationInterferon regulatory factor-1 is required for interferon-γ-induced MHC class I genes in astrocytes
Jarosinski, K. W., & Massa, P. T. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00467-2 · Cited by 37
JUNGWIRTH, C., Rebbert, M. L., Ozato, K., Degen, H.-J., Schultz, U., & Dawid, I. B. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3105 · Cited by 37
Self-citationWu, H., Yan, L., Shi, G., Du, S., Wang, X., Ye, W., Zhang, Z., Chu, Y., Ma, S., Wang, D., et al. (2022) · Hepatology · doi:10.1002/hep.32316 · Cited by 38
“Research shows that IRF8 represses transcription of ICS motif A/GNGAAANNGAAACT or positive regulatory domain I (PRDI; TCACTT or AAGTGA).[12,13] However, ChIP- qPCR revealed that IRF8 does not bind on CCL20 promoter (Figure S6A), suggesting that IRF8 does not directly repress CCL20 transcription, consistent with the pu…”
BackgroundResultApoptosis and Cell Growth Inhibition as Antitumor Effector Functions of Interferons
Sangfelt, O., & Strander, H. A. (2001) · Medical Oncology · doi:10.1385/mo:18:1:3 · Cited by 36
Leaman, D. W., Salvekar, A., Patel, R. C., Sen, G. C., & Stark, G. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9442 · Cited by 35
Bragança, J., Génin, P., Bandu, M., Darracq, N., Vignal, M., Cassé, C., Doly, J., & Civas, A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.35.22154 · Cited by 36
Thornton, A. M., Buller, R. M. L., DeVico, A. L., Wang, I. M., & Ozato, K. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.383 · Cited by 34
Self-citationRegulation of macrophage gene expression by T-cell-derived lymphokines.
Ohmori, Y., & Hamilton, T. A. (1994) · Pharmacology and Therapeutics · doi:10.1016/0163-7258(94)90026-4 · Cited by 46
Ward, L. A., & Massa, P. T. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00005-m · Cited by 31
Hu, G., Chen, X., Gong, Q., Liu, Q., Zhang, S., & Dong, X. (2013) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2013.06.016 · Cited by 30
Kim, M., Hwang, S., Park, K., Kim, S. Y., Lee, Y. K., & Lee, D. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120602 · Cited by 30
TRANSCRIPTIONAL REGULATION OF MHC CLASS I GENES
Girdlestone, J. (1996) · International Journal of Immunogenetics · doi:10.1111/j.1744-313x.1996.tb00015.x · Cited by 29
Expression of Nonclassical MHC Class Ib Genes: Comparison of Regulatory Elements
Howcroft, T. K., & Singer, D. S. (2003) · Immunologic Research · doi:10.1385/ir:27:1:1 · Cited by 29
HOBART, M. G., Ramassar, V., Goes, N. B., Urmson, J. R., & Halloran, P. F. (1996) · Transplantation · doi:10.1097/00007890-199612270-00037 · Cited by 29
Bovolenta, C., Lou, J., Kanno, Y., Park, B. K., Thornton, A. M., Coligan, J. E., Schubert, M., & Ozato, K. (1995) · Journal of Virology · doi:10.1128/jvi.69.7.4173-4181.1995 · Cited by 29
Self-citationTranscriptional control of interferon-stimulated genes
Babadei, O., Strobl, B., Müller, M. M., & Decker, T. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107771 · Cited by 28
Wang, Q., & Floyd-Smith, G. (1997) · DNA and Cell Biology · doi:10.1089/dna.1997.16.1385 · Cited by 26
“In addition to the ISRE, some IFN-a-inducible genes contain elements that bind cell growth regulatory factors (Au et al, 1995; Nelson et al, 1993) as well as other elements such as the GAS element (Schindler and Dar¬ nell, 1995) that may be required for transcriptional induction by IFN-(Khan et al,…”
Belicha‐Villanueva, A., Blickwedehl, J., McEvoy, S. M., Golding, M., Gollnick, S. O., & Bangia, N. (2009) · Immunologic Research · doi:10.1007/s12026-009-8123-8 · Cited by 25
“Whereas IRF-1 activates its transcription [90, 91] and IRF-2 represses it [92, 93].”
BackgroundRegulation of HLA Class I Loci by Interferons
Girdlestone, J. (1995) · Immunobiology · doi:10.1016/s0171-2985(11)80548-6 · Cited by 25
Martelli, A. M., Cocco, L., Bareggi, R., Tabellini, G., Rizzoli, R., Ghibellini, M. D., & Narducci, P. (1999) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19990301)72:3 · Cited by 38
Relevance of Interferon Regulatory Factor-8 Expression in Myeloid–Tumor Interactions
Abrams, S. I., Netherby, C. S., Twum, D. Y. F., & Messmer, M. N. (2016) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2015.0174 · Cited by 24
Regulation of gene expression at early stages of B-cell and T-cell differentation
Fitzsimmons, D., & Hagman, J. R. (1996) · Current Opinion in Immunology · doi:10.1016/s0952-7915(96)80054-9 · Cited by 24
Specific Deficiency in Nuclear Factor-κB Activation in Neurons of the Central Nervous System
Jarosinski, K. W., Whitney, L. W., & Massa, P. T. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780341 · Cited by 22
“Western Blot Analysis of p50, p65, and I B Whole cell extracts were prepared as previously described (Massa et al, 1992; Nelson et al, 1993).”
MethodBragança, J., & Civas, A. (1998) · Biochimie · doi:10.1016/s0300-9084(99)80021-2 · Cited by 21
Huang, X. F., Nandakumar, V., Tumurkhuu, G., Wang, T., Jiang, X., Hong, B., Jones, L. E., Won, H.-J., Yoshii, H., Ozato, K., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.162 · Cited by 24
Self-citationIn vivo formation of IRF-1 homodimers
Kirchhoff, S., Schaper, F., Oumard, A., & Häuser, H. (1998) · Biochimie · doi:10.1016/s0300-9084(99)80019-4 · Cited by 20
Cloning of an interferon regulatory factor 2 isoform with different regulatory ability
Merediz, S. A. K. X. F. N. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.21.4219 · Cited by 20
Massa, P. T., & Wu, H. (1995) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1995.15.799 · Cited by 19
“The slight induction IRF-2, the transcriptional antagonist of IRF-1,'28,39,59,82' because it is less abundant in astrocytes than IRF-1, may play a minor role in MHC class I gene expression in these cells.”
Bonaparte, K. L., Hudson, C. A., Wu, C. W., & Massa, P. T. (2006) · Glia · doi:10.1002/glia.20344 · Cited by 18
“Nuclear extracts from astrocytes were prepared using a mini-prep technique for analysis by EMSA, as de- GLIA DOI 10.1002/glia scribed previously (Garner and Rezvin, 1981; Massa et al., 1992; Nelson et al., 1993).”
MethodInfluentialWaring, J. F., Radford, J. E., Burns, L. J., & Ginder, G. D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.20.12276 · Cited by 18
Zavala, K., Gottlieb, C., Teles, R. M. B., Adams, J. S., Hewison, M., Modlin, R. L., & Liu, P. T. (2018) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006815 · Cited by 17
“edu/), which is a type I IFN inducible transcription factor with known gene suppression functions [29].”
BackgroundXAF1 prevents hyperproduction of type I interferon upon viral infection by targeting IRF7
Liu, B., Liu, R., Li, W., Mao, X.-T., Li, Y., Huang, T., Wang, H., Chen, H., Zhong, J.-Y., Yang, B., et al. (2022) · EMBO Reports · doi:10.15252/embr.202255387 · Cited by 17
“IRF4 and IRF8, identified later, were found to exhibit physiological functions similar to those of IRF2; however, the functions of IRF4 and IRF8 are multifaceted, as they exhibit opposite functions in different complexes (Nelson et al , 1993; Brass et al , 1996; Shaffer et al , 2009).”
Host Immunosurveillance Controls Tumor Growth via IFN Regulatory Factor-8–Dependent Mechanisms
Greeneltch, K. M., Schneider, M., Steinberg, S. M., Liewehr, D. J., Stewart, T. J., Liu, K., & Abrams, S. I. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1228 · Cited by 19
Kanno, Y., Kozak, C. A., Schindler, C., Driggers, P., Ennist, D. L., Gleason, S., Darnell, J. E., & Ozato, K. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.7.3951-3963.1993 · Cited by 185
Self-citationUeno, M., Sonoda, Y., Funakoshi, M., Mukaida, N., Nose, K., & Kasahara, T. (2000) · Cytokine · doi:10.1006/cyto.1999.0544 · Cited by 16
Chromatin Dynamics during Differentiation of Myeloid Cells
Schönheit, J., Leutz, A., & Rosenbauer, F. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.08.015 · Cited by 15
A Novel Transactivating Factor That Regulates Interferon-γ-dependent Gene Expression
Hu, J., Meng, Q., Roy, S. K., Raha, A., Hu, J., Zhang, J., Hashimoto, K., & Kalvakolanu, D. V. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202679200 · Cited by 15
REST Negatively and ISGF3 Positively Regulate the Human STAT1 Gene in Melanoma
Amalraj, J., Cutler, S. J., Ghazawi, I., Boyle, G. M., & Ralph, S. J. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0923 · Cited by 14
Shih, N., & Floyd-Smith, G. (1995) · Molecular Immunology · doi:10.1016/0161-5890(95)00029-e · Cited by 14
Kim, K. I., Lee, U. H., Cho, M., Jung, S., Min, E., & Park, J. W. (2020) · PLoS ONE · doi:10.1371/journal.pone.0239925 · Cited by 13
“IRF8, a transcription factor, is able to either inhibit [54, 55] or induce IFN gene transcription [56–58] depending on cell type and conditions.”
BackgroundWhite, C. L., Kessler, P., Dickerman, B. K., Ozato, K., & Sen, G. C. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.705467 · Cited by 13
Self-citationLi, S.-W., He, Y., Zheng, Z., Liu, D., & Liu, Z. (2013) · International Journal of Immunogenetics · doi:10.1111/iji.12087 · Cited by 13
“IRF8 also known as interferon consensus sequencebinding protein (ICSBP) is a key transcription factor that regulates myeloid cell and B-cell differentiation under physiologic conditions (Nelson et al., 1993; Wang et al., 2008; Wang & Morse, 2009).”
BackgroundRetinoic Acid-Inducible Gene I-Like Receptors Activate Snail To Limit RNA Viral Infections
Vedagiri, D., Gupta, D., Mishra, A., Krishna, G., Bhaskar, M., Sah, V., Basu, A., Nayak, D., Kalia, M., Veettil, M. V., et al. (2021) · Journal of Virology · doi:10.1128/jvi.01216-21 · Cited by 12
Cai, M., & Chen, N. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.817069 · Cited by 10
Sp2 regulates interferon-γ-mediated socs1 gene expression
Letourneur, M., Valentino, L., Travagli-Gross, J., Bertoglio, J. H., & Pierre, J. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.05.004 · Cited by 12
“ICSBP (IRF-8; FN consensus sequence binding protein) is also a repressor of IRF-dependent transcription (Nelson et al., 1993; Weisz et al., 1992). he absence of IRF-2 induction after IFN- stimulation led us to xclude the implication of this member of the IRF family in the nresponsiveness of the…”
BackgroundResponse and Resistance to Interferons and Interacting Cytokines
Borden, E. C., Waalen, J., Schreiber, R. D., & Williams, B. R. G. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.4.257 · Cited by 10
Transcriptional repression of type I IFN genes
Lopez, S., & Navarro, S. (1998) · Biochimie · doi:10.1016/s0300-9084(99)80022-4 · Cited by 10
The Role of the Placental Enzyme Indoleamine 2,3-Dioxygenase in Normal and Abnormal Human Pregnancy
Kudo, Y., & Sugimoto, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084577 · Cited by 9
“…pregnancies show that sequences corresponding to the promoter region in which signal transducer and activator of transcription1 binding site, interferon-γ activation site [53], or interferon-stimulated response element [54] is present, and exon 1 to exon 10 of the human IDO gene [55] appear normal.”
BackgroundPark, J. H., Kim, J. H., Jo, K. E., Na, S. W., Eisenhut, M., Kronbichler, A., Lee, K. H., & Shin, J. I. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0773-2 · Cited by 9
“Specifically, IRF8 binds to the upstream regulatory region or the IFN consensus sequence (ICS) of type 1 IFN and IFN-inducible MHC class I genes and is involved not only in the differentiation of CD8 dendritic cells [31] but also in the differentiation of macrophages [32], development of myeloid cells [33], and differ…”
A locus for eosinophilia in the MES rat is on Chromosome 19
Li, G., Guo, Z., Higuchi, K., Kawakubo, M., Matsumoto, K., & Mori, M. (2005) · Mammalian Genome · doi:10.1007/s00335-004-2454-5 · Cited by 9
“ICSBP1 is a transcription factor belonging to the interferon regulatory factor family which controls interferon responses (Nelson et al. 1993).”
BackgroundMa, S. L., Sørensen, A. B., Kunder, S., Sørensen, K. D., Quintanilla‐Martínez, L., Morris, D. W., Schmidt, J., & Pedersen, F. S. (2006) · Virology · doi:10.1016/j.virol.2006.05.006 · Cited by 8
“…IRFs, ICSBP is expressed exclusively in cells of the immune system such as monocytes/macrophages, dendritic cells, B-cells, and activated T-cells (Driggers et al., 1992; Lu et al., 2003; Nelson et al., 1993; Schiavoni et al., 2002; Tsujimura et al., 2002; Weisz et al., 1994; Weisz et al., 1992).”
BackgroundImpact of the transcription factor IRF8 on limbal epithelial progenitor cells in a mouse model
Kesper, C., Viestenz, A., Wiese-Rischke, C., Scheller, M., & Hammer, T. (2022) · Experimental Eye Research · doi:10.1016/j.exer.2022.108985 · Cited by 8
Yu, F. H. Z., & Floyd-Smith, G. (1999) · Cytokine · doi:10.1006/cyto.1998.0480 · Cited by 8
STEM CELLS IN CHRONIC MYELOGENOUS LEUKEMIA
Verfaillie, C. M. (1997) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70484-6 · Cited by 8
Wadler, S., & Schwartz, E. L. (1994) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00686280 · Cited by 8
Differential regulation of germinal center genes, BCL6 and SWAP-70, during the course of MAIDS
Qi, C., Jessberger, R., Torrey, T. A., Taddesse-Heath, L., Ohta, Y., & Morse, H. C. (1999) · Molecular Immunology · doi:10.1016/s0161-5890(99)00121-2 · Cited by 7
Chang, K., Han, K. S., Qiu, W., Hu, Z., Chen, X., Chen, X., Xie, X., Wang, S., Hu, C., & Mao, H. (2021) · Molecular Immunology · doi:10.1016/j.molimm.2021.04.020 · Cited by 6
Huo, W., Chen, M., Chang, C., Yu, J., Chen, D., & Wang, R. (2025) · Scientific Reports · doi:10.1038/s41598-025-94424-0 · Cited by 4
“It typically forms heterodimers with IRF1 and is induced by IFN and lipopolysaccharides in macrophages, collaboratively promoting transcription of macrophage functional genes 28,29 .”
The HIV latency reversing agent HODHBt inhibits the phosphatases PTPN1 and PTPN2
Howard, J. N., Zaikos, T. D., Levinger, C., Rivera, E., McMahon, E. K., Holmberg, C. S., Terao, J., Sanz, M., Copertino, D. C., Wang, W., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.179680 · Cited by 4
Signaling Molecules Affecting Immune Response
Hertzog, P. J., Fenner, J. E., & Mansell, A. S. (2005) · Elsevier eBooks · doi:10.1016/b978-012455900-4/50267-1 · Cited by 4
Zhu, C., Lindsey, S. C., Konieczna, I., & Eklund, E. A. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0807514 · Cited by 4
Characterization of novel dual PTPN1 and PTPN2 inhibitorsPreprint
Bosque, A., Howard, J. N., Zaikos, T. D., Levinger, C., Rivera, E., McMahon, E. K., Sanz, M., Copertino, D. C., Wang, W., Soriano-Sarabia, N., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2869323/v1 · Cited by 4
Silverman, N. (2006) · Digital Commons - University of South Florida (University of South Florida) · Cited by 2
Hayes, M. P., & Zoon, K. C. (1994) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7156-3_6 · Cited by 2
Cis- and trans-regulation of Irf8 enhancers during dendritic cell development
Nishiyama, A., & Tamura, T. (2025) · Experimental Hematology · doi:10.1016/j.exphem.2025.104858 · Cited by 1
Kalvakolanu, D., Mannino, S. B., Thornton, A., Ozato, K., & Borden, E. C. (1994) · Antiviral Research · doi:10.1016/0166-3542(94)90099-x · Cited by 1
Self-citationMechanisms of Transcriptional Regulation
Marecki, S., & Fenton, M. J. (2000) · Cited by 2
Virus Induced Signaling to Initiate the Interferon Mediated Anti-Viral Host Response
Wietek, C., & O'Neill, L. A. J. (2007) · Springer eBooks · doi:10.1007/0-387-27445-6_6
Transcription Factors: Deciphering the Transcription Factor Network of Dendritic Cell Development
Hieronymus, T., & Zenke, M. (2006) · Wiley eBooks · doi:10.1002/9783527619696.ch4
Regulation of transcription and analysis of drug targets in lymphoma and myeloma cells
Bolick, S. C. E. (2006) · Digital Commons - University of South Florida (University of South Florida)
Costa, C. H. (2011) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Huyghe, L. (2008) · Ghent University Academic Bibliography (Ghent University)
Uchiumi, F., Arakawa, J., Takihara, Y., Akui, M., Hamada, H., & Tanuma, S. (2018) · InTech eBooks · doi:10.5772/intechopen.71095
“The GGAAmotifs are also harbored in the IFN-stimulated response element (ISRE)-like sequences [28, 29].”
BackgroundGenetics of Multiple Sclerosis
Leppä, V. (2013) · Työväentutkimus Vuosikirja
Genes of the Major Histocompatibility Complex
(1998) · Springer eBooks · doi:10.1007/978-0-585-31180-7_1
Metadata
- Authors
- Nelson, N., Marks, M. S., Driggers, P. H., & Ozato, K.
- Affiliations
- National Institutes of Health (US)
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1993-01
- Volume
- 13
- Issue
- 1
- Pages
- 588-599
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC358938
- OpenAlex
- W1857506864
- Cited by
- 192
- References
- 83
- Citations by year
- 2025: 2 · 2024: 4 · 2023: 1 · 2022: 5 · 2021: 2 · 2020: 2 · 2018: 2 · 2017: 2 · 2016: 3 · 2015: 1 · 2014: 2 · 2013: 4 · 2012: 2
- FWCI
- 6.94
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Molecular and Cellular Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- IRF2, IRF1, interferon-stimulated response element, transcriptional repression, interferon-beta, retinoic acid, MHC class I, 2',5'-oligoadenylate synthetase, guanylate-binding proteins, DNA-binding domain, embryonal carcinoma cells
- MeSH terms
- Interferon Regulatory Factor-8, Base Sequence, Binding Sites, Carrier Proteins, Cells, Cultured, DNA-Binding Proteins, Enhancer Elements, Genetic, Gene Expression Regulation, Genes, MHC Class I, Humans, Interferons, Oligodeoxyribonucleotides, Phosphoproteins, Repressor Proteins, RNA, Messenger, Transcription Factors, Transcription, Genetic, Gene Expression, Polymerase Chain Reaction, Interferon-beta, Interferon Regulatory Factors, Interferon Regulatory Factor-2, Interferon Regulatory Factor-1, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review